About Alnes Pharma India Private Limited
Data last updated:
Alnes Pharma India Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U33100KA2021PTC144543. Its GSTIN is 29AAUCA8322J1Z2 (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Negalaguli Aravinda and Ademane Prabhavati.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹95.58 Lakh, a growth of 25% compared to the previous year. For the same year it recorded a net loss of ₹96.34 Lakh (net margin -100.8%) and EBITDA of -₹87.18 Lakh (EBITDA margin -91.2%). Revenue has grown at a compounded annual rate (CAGR) of 67% over three years.
The company has about 35 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹55 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alnespharma.in.
Company details
Contact details
Alnes Pharma India Private Limited's registered office is in Bangalore, Karnataka. Its website is alnespharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo 803 3rd Floor B Sector Mig Khb Colony, 100 Ft Mother Dairy Road, Bangalore, Karnataka, India – 560064
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Alnes Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Alnes Pharma India is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Alnes Pharma India Private Limited, buy the company report.
Financials of Alnes Pharma India Private Limited
FY 2025 filings availableAlnes Pharma India Private Limited reported revenue of ₹95.58 Lakh (up 25% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 67% over three years, including 25% growth in the latest year. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹87.18 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹96.34 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -91.2% | ||||
| Net Profit Margin | -100.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alnes Pharma India Private Limited, buy the company report.
Board of directors of Alnes Pharma India Private Limited
Alnes Pharma India has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Negalaguli Aravinda | Director | 24 Feb 2021 | 5 Years 8 Months | Current |
| Ademane Prabhavati | Director | 24 Feb 2021 | 5 Years 8 Months | Current |
| Suresha Eranna Also directs: Amrutha Diagnostic Centre India Private Limited | Director | 24 Feb 2021 | 5 Years 8 Months | Current |
Peer comparison
Alnes Pharma India Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Veenit Builders Private Limited | ₹95.83 Lakh (FY 2025) | -40.0% | New Delhi, Delhi, India | |||
| Alchemeco Pharma Private Limited | ₹95.75 Lakh (FY 2025) | 30.0% | Cherlapally, Telangana, India | |||
| One Dream Fitness & Clubs Private Limited | ₹95.7 Lakh (FY 2025) | 2.0% | Delhi, India | |||
| SLPT Motors Private Limited | ₹95.66 Lakh (FY 2025) | -57.0% | Gadag, Karnataka, India | |||
| League of Legends Private Limited | ₹95.63 Lakh (FY 2025) | 2057.0% | Nashik, Maharashtra, India | |||
| Alnes Pharma India Private Limitedthis company | ₹95.58 Lakh (FY 2025) | -₹96.34 Lakh | -100.8% | 25.0% | Bangalore, Karnataka, India | |
| Fairlink Projects Advisory Private Limited | ₹95.5 Lakh (FY 2025) | -3.0% | Kolkata, West Bengal, India | |||
| Joyoum Cemcast Private Limited | ₹95.45 Lakh (FY 2024) | -48.0% | Kolkata, West Bengal, India | |||
| Sanghvi Constructions Private Limited | ₹95.3 Lakh (FY 2025) | -51.0% | Mumbai, Maharashtra, India | |||
| Intan Exports Private Limited | ₹95.2 Lakh (FY 2025) | 97.0% | Mumbai, Maharashtra, India | |||
| Lakhdatar Fastgrow Private Limited | ₹95.2 Lakh (FY 2024) | 26.0% | Udaipur, Rajasthan, India |
To see the full peer comparison of Alnes Pharma India Private Limited, buy the company report.
Auditor
Alnes Pharma India Private Limited is audited by N N YUVARAJ AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N N YUVARAJ AND ASSOCIATES | FY 2023 | 005137S |
Shareholding
The shareholding of Alnes Pharma India Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Alnes Pharma India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Aug 2024 | 100969681 | Others | ₹45 Lakh | Open | |
| 12 May 2022 | 100577904 | Others | ₹10 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Alnes Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alnes Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Alnes Pharma India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAUCA8322J1Z2 | Karnataka | Active | 31 Mar 2021 |
To see the full GST registrations and return filing status of Alnes Pharma India Private Limited, buy the company report.
Recent activity
Alnes Pharma India Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Ademane Prabhavati was appointed as Director on 24 Feb 2021.
Frequently asked questions
Alnes Pharma India is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 February 2021 (5+ years old) and is registered under CIN U33100KA2021PTC144543.
Alnes Pharma India has 3 current directors:
- Negalaguli Aravinda - Director
- Ademane Prabhavati - Director
- Suresha Eranna - Director
The latest financial statements of Alnes Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Alnes Pharma India is 29AAUCA8322J1Z2, registered in Karnataka.
The CIN (Corporate Identification Number) of Alnes Pharma India is U33100KA2021PTC144543. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alnes Pharma India was incorporated on 24 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Alnes Pharma India by revenue are Veenit Builders Private Limited, Alchemeco Pharma Private Limited, One Dream Fitness & Clubs Private Limited, SLPT Motors Private Limited, League of Legends Private Limited and 5 more, all in the same principal business activity (retail trade, except of motor vehicles and motorcycles).
Ademane Prabhavati was appointed as Director on 24 Feb 2021. Negalaguli Aravinda was appointed as Director on 24 Feb 2021. Suresha Eranna was appointed as Director on 24 Feb 2021.
Alnes Pharma India can be reached through the website alnespharma.in. Its registered office is in Bangalore, Karnataka, India.
The registered office of Alnes Pharma India is at No 803 3rd Floor B Sector Mig Khb Colony, 100 Ft Mother Dairy Road, Bangalore, Karnataka, India – 560064.
Alnes Pharma India operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
